Company intelligence / Profile preview

Medicaroid

Ownership: Private
Development stage: Other

Overview

The hinotori Surgical Robot System by Medicaroid has received regulatory approval for urology, gastroenterology, gynecology, general surgery, thoracic surgery in Japan; it has also been approved in Singapore. Clinical use has expanded across several medical institutions with ongoing applications for additional surgical fields such as respiratory surgery. No drug clinical results as the company focuses on devices.

Therapeutic areas: PulmonologyMen's HealthGastroenterologyOtherWomen's Health
Modalities: DeviceRobotic-assisted surgery system
Industry: Surgical Medical Devices

Partnerships

Kawasaki Heavy IndustriesSysmex CorporationOPTiM

Beyond the preview

Go deeper on Medicaroid.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicaroid.

Explore the full profile